Literature DB >> 18241623

Role of hepatic resection for patients with carcinoid heart disease.

Alain M Bernheim1, Heidi M Connolly, Joseph Rubin, Jacob E Møller, Christopher G Scott, David M Nagorney, Patricia A Pellikka.   

Abstract

OBJECTIVE: To evaluate the effects of resection of hepatic carcinoid metastases on progression and prognosis of carcinoid heart disease. PATIENTS AND METHODS: From our database of 265 consecutive patients diagnosed as having carcinoid heart disease from January 1, 1980, through December 31, 2005, we calculated survival from first diagnosis of cardiac involvement. Hepatic resection during follow-up was entered as a time-dependent covariable in a multivariable analysis. In patients with serial echocardiograms more than 1 year apart without intervening cardiac surgery, a previously validated cardiac severity score was calculated. A score increase that exceeded 25% was considered relevant progression.
RESULTS: Hepatic resection was performed in 31 patients (12%) during follow-up. Five-year survival was significantly higher in these patients (86.5%; 95% confidence interval [CI], 73.5%-100.0%) than in patients without hepatic resection (29.0%; 95% CI, 23.3%-36.1%; univariable hazard ratio for hepatic resection, 0.25; 95% CI 0.12-0.53; P<.001). Hepatic resection remained strongly associated with improved prognosis in multivariable analysis (hazard ratio, 0.31; 95% CI, 0.14-0.66; P=.003). Among 77 patients (29%) with serial echocardiograms, 10 (13%) underwent hepatic resection during follow-up; resection was independently associated with decreased risk of cardiac progression (odds ratio, 0.29; 95% CI, 0.06-0.75; P=.03).
CONCLUSION: Despite the limitations of this retrospective nonrandomized study, our data suggest that patients with carcinoid heart disease who undergo hepatic resection have decreased cardiac progression and improved prognosis. Eligible patients should be considered for hepatic surgery.

Entities:  

Mesh:

Year:  2008        PMID: 18241623     DOI: 10.4065/83.2.143

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  10 in total

Review 1.  Ileal neuroendocrine tumors and heart: not only valvular consequences.

Authors:  Jan Calissendorff; Eva Maret; Anders Sundin; Henrik Falhammar
Journal:  Endocrine       Date:  2014-10-16       Impact factor: 3.633

Review 2.  Carcinoid-syndrome: recent advances, current status and controversies.

Authors:  Tetsuhide Ito; Lingaku Lee; Robert T Jensen
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2018-02       Impact factor: 3.243

3.  Carcinoid valve disease.

Authors:  J Wells Askew; Heidi M Connolly
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-10

Review 4.  Multimodal management of neuroendocrine liver metastases.

Authors:  Andrea Frilling; Georgios C Sotiropoulos; Jun Li; Oskar Kornasiewicz; Ursula Plöckinger
Journal:  HPB (Oxford)       Date:  2010-08       Impact factor: 3.647

5.  Multimodal liver-directed management of neuroendocrine hepatic metastases.

Authors:  Mark A Lewis; Joleen Hubbard
Journal:  Int J Hepatol       Date:  2011-10-29

Review 6.  Update in carcinoid heart disease - the heart of the matter.

Authors:  Kira Oleinikov; Amit Korach; David Planer; Dan Gilon; Simona Grozinsky-Glasberg
Journal:  Rev Endocr Metab Disord       Date:  2021-01-14       Impact factor: 9.306

Review 7.  Complications from carcinoid syndrome: review of the current evidence.

Authors:  José Mauricio Mota; Luana Guimarães Sousa; Rachel P Riechelmann
Journal:  Ecancermedicalscience       Date:  2016-08-08

8.  Carcinoid Heart Disease: Starting From Heart Failure.

Authors:  Nicole Bertin; Serena Favretto; Francesco Pelizzo; Lucio Mos; Franco Pertoldi; Olga Vriz
Journal:  J Investig Med High Impact Case Rep       Date:  2017-06-08

9.  Tricuspid valve regurgitation as a presenting symptom of metastasized carcinoid tumor.

Authors:  Anton F Engelsman; Peter van Duijvendijk; Bjorn E Groenemeijer; Edwin van der Zaag; Peter E Spronk; Alex Katinakis
Journal:  Case Rep Gastroenterol       Date:  2012-09-29

10.  Serial surveillance of carcinoid heart disease: factors associated with echocardiographic progression and mortality.

Authors:  R Dobson; M I Burgess; J W Valle; D M Pritchard; J Vora; C Wong; C Chadwick; B Keevi; J Adaway; U Hofmann; G J Poston; D J Cuthbertson
Journal:  Br J Cancer       Date:  2014-09-11       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.